Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;78(1):51-57.
doi: 10.1016/j.jjcc.2020.12.013. Epub 2020 Dec 30.

Uric acid and cardiovascular disease: A clinical review

Affiliations
Free article
Review

Uric acid and cardiovascular disease: A clinical review

Yuichi Saito et al. J Cardiol. 2021 Jul.
Free article

Abstract

Uric acid, the end-product of purine metabolism in humans, is not only a cause of gout, but also may play roles in developing cardiovascular diseases such as hypertension, atrial fibrillation, chronic kidney disease, heart failure, coronary artery disease, and cardiovascular death. Several clinical investigations have reported serum uric acid as a predictive marker for cardiovascular outcomes. Although the causal relationship of hyperuricemia to cardiovascular diseases remains controversial, there has been a growing interest in uric acid because of the increased prevalence of hyperuricemia worldwide. This review article summarizes current evidence concerning the relation between hyperuricemia and cardiovascular diseases.

Keywords: Cardiovascular disease; Outcome; Uric acid.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Yuichi Saito, Atsushi Tanaka, and Yoshio Kobayashi declare no conflicts of interest to disclose. Koichi Node reports research grants from Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, and Terumo, scholarship grants from Astellas, Bayer Yakuhin, Bristol-Myers Squibb, Daiichi Sankyo Healthcare, Takeda Pharmaceutical, Teijin Pharma, and honoraria from Astellas, AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, MSD, Novo Nordisk Pharma, Ono Pharmaceutical, Takeda Pharmaceutical, and Teijin Pharma.

Similar articles

Cited by

LinkOut - more resources